Almirall (ES:ALM) has released an update. Almirall, S.A. is set to present and discuss its financial results for the first nine months of 2024 via a webcast with analysts and institutional investors.
Almirall (BME: ALM), the Spain-based biopharma, reported a 7.9% increase in net sales for the first nine months of 2024, reaching 728 million euros ($775 million), and an EBITDA rise of 2.9% to $152 ...
Kikuchi–Fujimoto disease (KFD), histiocytic necrotising lymphadenitis, is a benign and self-limiting disease characterised ...
Axcelis Technologies, Inc. today announced financial results for the third quarter ended September 30, 2024. The Company reported third quarter revenue of $256.6 million, compared to $256.5 million ...
Goalkeeper Jimmy Corcoran proved Bray Wanderers' penalty shootout hero as the Seagulls soared back from 2-0 down to win a ...
Almirall has put patients’ friends and family at the heart of its activities for the 2024 World Psoriasis Day, ...
Speakers from Almirall, AstraZeneca, Bayer, BioNTech, Glenmark, and GSK share innovative approaches to drive commercial excellence BARCELONA, Spain, Oct. 29, 2024 /PRNewswire/ -- Veeva ...
Veeva Systems (NYSE: VEEV) today announced that leaders from Almirall, AstraZeneca, Bayer AG, BioNTech SE, Glenmark, and GSK ...
The third edition of ImmunoSkin underscored Almirall’s commitment to advancing the scientific understanding of skin and its diseases, and to pioneering innovation in medical dermatology and ...
Well-taken goals in each half from Guillermo Almirall and Cristian Magerusan has Bray Wanderers in the driving seat ahead of the second leg of their First Division play-off semi-final with UCD. Bray, ...
Almirall has completed the decentralised European regulatory procedure for efinaconazole, a triazole antifungal substance with the trade name Jublia, to treat onychomycosis. This is a significant ...
BARCELONA, Spain, October 15, 2024--(BUSINESS WIRE)--Almirall, S.A. (ALM), a global pharmaceutical company dedicated to medical dermatology announced today the successful completion of the ...